CPIX supply chain intelligence for Cumberland Pharmaceuticals Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| APOTEX-INC | APOTEX-INC | 92% | Through the Transaction Apotex will create a U.S. branded pharmaceutical platform to build upon, by delivering specialty medicines that improve the quality of patient care. |
| 1600-WEST-END-AVENUE-PARTNERS-LLC | 1600-WEST-END-AVENUE-PARTNERS-LLC | 90% | On November 15, 2021, Cumberland entered into a lease (the "Broadwest Lease"), pursuant to which the Company leases approximately 16,903 rentable square feet of space (the "Leased Premise") at the Br… |
| KYOWA-KIRIN-INC | KYOWA-KIRIN-INC | 90% | On January 3, 2022, Cumberland acquired the U.S. rights to the FDA-approved oncology-supportive care medicine Sancuso from Kyowa Kirin, Inc. ("Kyowa Kirin"), the U.S. affiliate of Japan-based Kyowa K… |
| NORDIC-B-V | NORDIC-B-V | 90% | Effective June 30, 2023, the Company returned all rights of RediTrex back to Nordic B.V., and will receive a long-term royalty on any sales of the product in the future. |
| THERAVANCE | THERAVANCE | 80% | The contingent consideration earned and accrued in operating expenses is paid to Theravance quarterly. |
| HRTX | Heron Therapeutics, Inc. | 72% | Reciprocal relationship from HRTX graph: Reciprocal relationship from CPIX graph: Reciprocal relationship from HRTX graph: Reciprocal relationship from CPIX graph: Reciprocal relationship from HRTX g… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CHINA-DISTRIBUTION-PARTNER | CHINA-DISTRIBUTION-PARTNER | 90% | In early 2025, Cumberland received a $ 3.0 million milestone payment from our distribution partner in China associated with the approval of Vibativ for that market. |
| HRTX | Heron Therapeutics, Inc. | 72% | Reciprocal relationship from HRTX graph: omer-based composition. Furthermore, our Biochronomer Technology is designed to permit more than one pharmacological agent to be incorporated, such that multi… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| CPIX-DEBT | Debt stack $10.1M | 90% | Market cache reports total debt of $10.1M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| CPIX-OWNER-VANGUARD-GROUP-INC | Vanguard Group Inc | 95% | 13F/ownership overlay lists Vanguard Group Inc; shares held 411,786; ownership 2.75%; value $1.3M; as of 2025-12-31. |
| CPIX-OWNER-BRIDGEWAY-CAPITAL-MANAGEMENT-LLC | Bridgeway Capital Management, LLC | 95% | 13F/ownership overlay lists Bridgeway Capital Management, LLC; shares held 163,468; ownership 1.09%; value $498,577; as of 2025-12-31. |
| CPIX-OWNER-PERCEPTIVE-ADVISORS-LLC | Perceptive Advisors Llc | 95% | 13F/ownership overlay lists Perceptive Advisors Llc; shares held 341,087; ownership 2.28%; value $1.0M; as of 2025-12-31. |
| CPIX-OWNER-J-GOLDMAN-CO-L-P | J. Goldman & Co., L.P. | 95% | 13F/ownership overlay lists J. Goldman & Co., L.P.; shares held 94,541; ownership 0.63%; value $288,350; as of 2025-12-31. |
| CPIX-OWNER-DIMENSIONAL-FUND-ADVISORS-LP | Dimensional Fund Advisors LP | 95% | 13F/ownership overlay lists Dimensional Fund Advisors LP; shares held 272,278; ownership 1.82%; value $830,447; as of 2025-12-31. |
| CPIX-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | Geode Capital Management, LLC | 95% | 13F/ownership overlay lists Geode Capital Management, LLC; shares held 107,274; ownership 0.72%; value $327,185; as of 2025-12-31. |
| CPIX-OWNER-BANK-OF-NEW-YORK-MELLON-CORPORATION | Bank Of New York Mellon Corporation | 95% | 13F/ownership overlay lists Bank Of New York Mellon Corporation; shares held 72,513; ownership 0.48%; value $221,164; as of 2025-12-31. |
| CPIX-OWNER-IKARIAN-CAPITAL-LLC | Ikarian Capital, LLC | 95% | 13F/ownership overlay lists Ikarian Capital, LLC; shares held 555,932; ownership 3.72%; value $1.7M; as of 2025-12-31. |
| CPIX-OWNER-RENAISSANCE-TECHNOLOGIES-LLC | Renaissance Technologies, LLC | 95% | 13F/ownership overlay lists Renaissance Technologies, LLC; shares held 472,163; ownership 3.16%; value $1.4M; as of 2025-12-31. |
| CPIX-OWNER-BOOTHBAY-FUND-MANAGEMENT-LLC | Boothbay Fund Management, LLC | 95% | 13F/ownership overlay lists Boothbay Fund Management, LLC; shares held 128,507; ownership 0.86%; value $391,946; as of 2025-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| HRTX | Heron Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| HTGC | Hercules Capital, Inc. | 50.00 | 2 | |
| ORANY | ORANGE | 50.00 | 2 | |
| TKPHF | Takeda Pharmaceutical Company Limited | 50.00 | 2 | |
| MRK | Merck & Co., Inc. | 50.00 | 2 | |
| PCRX | Pacira BioSciences, Inc. | 50.00 | 2 |